retin
autoantibodi
commonli
refer
antiretin
antibodi
ara
implic
pathogen
varieti
immunemedi
visual
disord
paraneoplast
syndrom
cancerassoci
retinopathi
car
ara
target
retin
antigen
identifi
mani
infecti
inflammatori
well
degen
retinopathi
associ
presenc
ara
ara
identifi
car
autoantibodi
autoantigen
still
remain
unknown
recoverin
calciumbind
retin
protein
involv
revers
phototransduct
cascad
well
establish
common
car
autoantigen
propos
mechan
antibodymedi
degener
involv
molecular
mimicri
loss
peripher
toler
resid
retin
antigen
vitro
ara
shown
caus
apoptot
death
photoreceptor
question
remain
though
regard
access
penetr
antibodi
retina
furthermor
titer
ara
alway
correl
clinic
diseas
statu
exist
lack
standard
antibodi
antigen
detect
thu
result
differ
laboratori
exactli
compar
sensit
specif
detect
pathogen
ara
also
lack
though
mani
caveat
presenc
ara
still
serv
adjunct
studi
clinician
confirm
diagnosi
often
difficult
make
studi
ara
serv
excel
model
elucid
patholog
mechan
underli
autoimmun
retinopathi
alli
disord
sawyer
selhorst
zimmerman
hoyt
report
first
case
paraneoplast
retin
degener
three
patient
harbor
oat
cell
carcinoma
lung
although
metastat
diseas
present
three
includ
one
mening
carcinomatosi
none
autopsi
eye
show
evid
metastasi
retina
optic
nerv
part
visual
pathway
patient
present
clinic
triad
visual
symptom
ring
scotoma
narrow
retin
arteriol
subsequ
kornguth
associ
show
use
immunohistochemistri
serum
patient
smallcel
carcinoma
react
retin
ganglion
cell
high
titer
thick
section
cat
dog
human
retina
compar
control
begin
mani
studi
follow
retin
autoantibodi
commonli
known
antiretin
antibodi
ara
keltner
associ
hypothes
ara
play
role
mechan
underli
paraneoplast
retinopathi
well
retin
degen
diseas
retin
pigmentosa
field
autoimmunerel
retinopathi
air
born
cancerassoci
retinopathi
car
coin
thirkil
et
al
serv
primari
clinic
model
studi
air
current
recogn
retin
autoantigen
implic
car
tabl
immunohistochemistri
use
detect
autoantibodi
specif
retin
protein
western
immunoblot
becam
avail
whole
retin
extract
use
identif
aratarget
protein
reactiv
report
titer
molecular
weight
retin
santigen
first
retin
autoantigen
identifi
experi
guinea
pig
santigen
also
known
arrestin
first
candid
antigen
car
howev
dizhoor
polan
independ
show
recoverin
kda
protein
car
retin
autoantigen
interest
recoverin
remain
wellstudi
autoantigen
car
air
recoverin
calciumbind
protein
name
role
revers
phototransduct
cascad
regul
rhodopsin
phosphoryl
present
rod
cone
cone
bipolar
cell
rare
popul
retin
ganglion
cell
optic
nerv
optic
tectum
pineal
bodi
ara
recoverin
consid
pathogen
postul
aberr
product
recoverin
cancer
cell
lead
loss
toler
thu
product
antirecoverin
antibodi
ara
gain
access
recoverin
photoreceptor
induc
apoptosi
cancer
cell
line
car
patient
small
cell
carcinoma
lung
shown
produc
recoverin
sequenc
recoverin
report
follow
speci
human
cow
dog
mous
rat
zebrafish
ferret
hors
intravitr
inject
lewi
rat
recoverin
experiment
autoimmun
uveoretin
eau
model
induc
panuv
without
vascul
subsequ
retin
degener
model
resembl
car
clinic
degre
inflamm
induc
antigen
santigen
intraretinalbind
protein
irbp
also
induc
similar
inflammatori
reaction
eau
anoth
model
call
experiment
cancerinduc
retinopathi
ecir
induc
less
inflamm
clinic
analog
car
anoth
wellknown
autoantigen
enolas
kda
neuron
protein
adamu
shown
conform
epitop
confirm
pathogen
antienolas
antibodi
car
mani
autoantigen
list
tabl
character
known
molecular
weight
reactiv
western
blot
cross
associ
reveal
kda
protein
name
collaps
responsemedi
famili
autoantigen
paraneoplast
syndrom
involv
retin
optic
neuriti
posterior
vitriti
sometim
accompani
neurolog
symptom
cerebellar
ataxia
anoth
autoimmunerel
retinopathi
associ
paraneoplast
syndrom
melanomaassoci
retinopathi
mar
patient
often
alreadi
diagnos
cutan
malign
melanoma
contrast
patient
car
present
malign
manifest
result
symptom
workup
initi
reveal
underli
malign
mar
patient
like
complain
dazzl
photopsia
rapid
loss
vision
occur
period
week
serum
reactiv
western
immunoblot
often
reveal
reactiv
mar
result
antigen
propos
lipid
carbohydr
nevertheless
recent
evid
implic
three
possibl
candid
antigen
kda
protein
cell
kda
neuron
protein
transducin
gold
standard
diagnosi
mar
develop
milam
colleagu
first
show
mar
serum
reactiv
bipolar
cell
retin
tissu
section
novel
techniqu
screen
melanoma
cdna
phage
librari
use
sera
patient
mar
reveal
possibl
autoantigen
implic
pathogenesi
mar
antiretin
autoantibodi
specif
antibodi
direct
differ
popul
cell
retina
mani
differ
autoantigen
found
character
hook
develop
classif
schema
elabor
tabl
ara
present
paraneoplast
infecti
inflammatori
degen
retin
diseas
antiren
autoantibodi
detect
either
western
blot
analysi
serum
use
whole
retin
extract
immunohistochemistri
section
retin
tissu
tissu
varieti
speci
use
includ
human
monkey
cow
pig
mous
rat
make
standard
result
difficult
amongst
laboratori
elisa
particularli
use
commerci
test
develop
use
techniqu
detect
antirecoverin
antibodi
note
adamu
certain
ara
may
detect
western
immunoblot
due
sodium
dodecylsulf
denatur
autoantigen
loss
conform
epitop
presenc
antirecoverin
antibodi
often
diagnost
car
howev
gener
presenc
ara
diseas
may
alway
correl
predict
diseas
type
statu
antirecoverin
antibodi
found
patient
air
malign
certain
ara
profil
may
predict
correct
paraneoplast
syndrom
exampl
presenc
anti
antigen
antibodi
found
associ
nonparaneoplast
diseas
acut
dissemin
encephalomyel
addit
serum
reactiv
western
blot
alway
confer
immunohistochem
reactiv
retin
section
thu
complic
matter
pathogen
role
ara
need
confirm
otherwis
antibodi
could
epiphenomenon
putatit
pathogen
role
antirecoverin
antibodi
wellstudi
antibodi
car
deduc
follow
observ
antirecoverin
antibodi
occur
high
titer
car
tumor
cell
patient
car
shown
express
recoverin
howev
function
tumor
cell
unknown
immunohistochemistri
car
patient
serum
confirm
reactiv
photoreceptor
recoverin
resid
apoptosi
induc
vitro
vivo
antirecoverin
antibodi
involv
extracellular
potassium
calcium
mcginni
laboratori
shown
vitro
increas
extracellular
potassium
inhibit
antirecoverininduc
apoptosi
vivo
retin
dysfunct
improv
administ
nilvadipin
calcium
channel
blocker
lewi
rat
receiv
intravitr
inject
antirecoverin
antibodi
anoth
calcium
channel
blocker
nifedipin
also
prevent
antirecoverininduc
apoptosi
question
regard
exact
mechan
ara
enter
photoreceptor
induc
apoptosi
still
remain
answer
one
theori
enter
cell
via
endocytosi
eventu
induc
apoptosi
activ
pathway
anoth
model
shown
treatment
ciliari
neurotroph
factor
cntf
gene
transfer
protect
photoreceptor
antibodymedi
apoptosi
via
activ
suppress
activ
data
regard
genet
predisposit
car
paraneoplast
retinopathi
associ
ara
lack
maeda
identifi
antitumor
cytotox
lymphocyt
specif
recoverin
epitop
posit
car
patient
author
specul
could
reason
cancer
patient
car
better
prognosi
car
neg
cancer
patient
remain
controversi
diseas
preval
data
lack
ara
paraneoplast
syndrom
rare
diseas
cancerassoci
retinopathi
probabl
develop
much
less
common
paraneoplast
entiti
cerbellar
neuromuscular
diseas
presenc
ara
detect
normal
literatur
need
better
studi
specif
ara
probabl
high
western
immunoblot
immunohistochemistri
neither
sensit
exact
specif
sensit
need
accur
identifi
autoantigen
character
elisa
quit
specif
clinic
suspicion
high
prognost
valu
ara
debat
argu
melanoma
patient
mar
prolong
surviv
compar
melanoma
patient
mar
other
report
surviv
delay
patient
mar
modifi
treatment
spontan
improv
visual
function
without
treatment
never
report
treatment
prednison
ivig
shown
promis
normal
antibodi
titer
car
patient
rebound
titer
also
correl
return
symptom
recurr
cancer
patient
antienolas
antibodi
air
improv
steroid
treatment
summari
correl
quit
poor
titer
diseas
activ
retin
autoantibodi
play
role
produc
immunemedi
vision
loss
autoimmunerel
retinopathi
cancerassoci
retinopathi
car
rare
paraneoplast
diseas
direct
recoverin
photoreceptor
protein
involv
phototransductionserv
clinic
model
studi
pathogen
retin
autoantibodi
vitro
vivo
studi
shown
retin
autoantibodi
caus
apoptosi
target
cell
photoreceptor
autoantigen
implic
car
howev
mani
put
function
associ
anitretin
antibodi
remain
elucid
though
sensit
specif
pathogen
retin
autoantibodi
determin
presenc
still
serv
import
adjunct
data
assist
clinician
make
diagnos
